In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse ...

This article discusses the reliability of children who are called as witnesses in court cases.

NTT Research, Inc., a division of NTT (TYO:9432), and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced the publication of research showing an application of ...

Clean energy installations in the U.S. reached a record high last year, with the country adding 47% more capacity than in ...

Interdisciplinary research teams strive for innovative approaches to cultural heritage preservation, funded by the National ...

Needham raised the firm’s price target on Confluent (CFLT) to $40 from $31 and keeps a Buy rating on the shares after its Q4 earnings beat.

There are reports of IT sabotage, cyber espionage, and other acts of hybrid warfare almost every day. Communication networks ...

Deep Research is currently powered by Gemini 1.5 Pro. Google will presumably use 2.0 Pro once that exits the experimental phase, but it’s unclear when that upgrade will happen.

Managers often grapple with whether to be lenient or punitive when addressing employee misconduct. While leniency may seem ...

‎The Attorney General’s Office reported yesterday that the chairman of Waha Oil Company has been detained for several charges, including a LD 770 million contract fraud.

Diarrheagenic E. coli (DEC) is a major global cause of diarrheal diseases, with certain strains showing alarming levels of antibiotic resistance.